Skip to content
Smart Money

Pharmaceuticals

IBLHL IBL HealthCare Limited

Latest results: FY2026 · Jun 2026

Last close · 16 Oct 2026

Rs 41.37 -0.22%

Annual · FY2011 – FY2026

IBL HealthCare Limited (IBLHL) financial ratios

IBL HealthCare Limited earned a net margin of 4.8% in FY2026 against a five-year average of 5.2% (Pharmaceuticals median 9.4%). Return on equity was 9.1%, compared with a sector median of 21.7%. The current ratio stood at 2.30× and debt was 1.0% of equity. Cash took about 100 days to cycle through receivables, inventory and payables.

FY2026 vs the Pharmaceuticals median

Gross margin
35.7%
Sector median 37.0%
Net margin
4.8%
Sector median 9.4%
Return on equity (ROE)
9.1%
Sector median 21.7%
Return on assets (ROA)
5.5%
Sector median 11.7%
Current ratio
2.30×
Sector median 1.79×
Debt to equity
1.0%
Sector median 5.8%
Asset turnover
1.15×
Sector median 1.26×

Median of the 14 companies in the sector with the figure for their latest fiscal year.

IBLHL financial ratios (annual) (Rs mn)
Rs mn FY2026 Jul 2025 – Jun 2026 FY2025 Jul 2024 – Jun 2025 FY2024 Jul 2023 – Jun 2024 FY2023 * Jul 2022 – Jun 2023 FY2022 Jul 2021 – Jun 2022
Profitability
Gross margin 35.7% 33.5% 26.4% 33.3% 34.4%
EBITDA margin — 10.5% 4.2% 15.9% 16.2%
Operating margin — 10.3% 4.0% 15.7% 16.0%
Pre-tax margin 8.7% 7.9% 0.8% 11.4% 13.2%
Net margin 4.8% 4.8% 0.2% 7.7% 8.3%
Effective tax rate 45.1% 38.8% 73.9% 32.7% 37.3%
Returns
Return on equity (ROE) 9.1% 9.4% 0.4% 15.6% 17.4%
Return on assets (ROA) 5.5% 5.7% 0.2% 9.5% 11.3%
Return on invested capital (ROIC) 9.7% 10.6% 1.1% 15.5% 15.9%
Liquidity
Current ratio 2.30× 2.02× 2.24× 2.05× 2.20×
Quick ratio 1.70× 1.26× 1.49× 1.23× 1.28×
Leverage
Debt to equity 1.0% 6.8% 1.1% 14.1% 14.3%
Debt to capital 1.0% 6.4% 1.0% 12.4% 12.5%
Debt to assets 0.7% 4.0% 0.7% 8.4% 9.1%
Assets to equity 1.65× 1.65× 1.63× 1.63× 1.55×
Efficiency
Asset turnover 1.15× 1.18× 1.05× 1.24× 1.36×
Receivable days days 145 141 158 133 115
Inventory days days 133 138 145 147 129
Payable days days 178 165 153 128 102
Cash conversion cycle days 100 114 149 153 141
Dividends
Dividend payout ratio — 0.0% 0.0% 23.1% 21.4%
Earnings retention rate — 1.00× 1.00× 0.77× 0.79×

Ratios as reported for each fiscal year; returns are on average equity / assets. Debt ratios are percentages; turnover in times; working-capital measures in days.

IBLHL: frequently asked questions

What is IBLHL's EPS?

IBL HealthCare Limited reported basic earnings per share of Rs 2.24 for FY2026 (Jul 2025 – Jun 2026).

What is IBLHL's P/E ratio?

At the closing price of Rs 41.37 on 16 Oct 2026, IBLHL trades at a P/E of 18.5× based on EPS of Rs 2.24 (FY2026).

What was IBLHL's revenue and profit in FY2026?

IBL HealthCare Limited reported revenue of Rs 4.6 bn and profit attributable to shareholders of Rs 220.4 mn for FY2026 (Jul 2025 – Jun 2026).

Information only, not investment advice.